Copyright
©The Author(s) 2021.
World J Hepatol. Sep 27, 2021; 13(9): 1154-1166
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1154
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1154
Disorder | Biomarker changes | Ref. |
Liver steatosis | ↓ Liver mass, ↓ content of triglycerides, free fatty acids, and cholesterol in the liver tissues | [50-52,54] |
Liver inflammation | ↓ Myeloperoxidase activity, expression of tumor necrosis factor alpha gene and neutrophil infiltration in the liver | [54] |
Oxidative stress in liver | ↓ Level of nitric oxide and malondialdehyde and ↑ level of glutathione and catalase in the liver tissue | [50,51,54] |
Death of hepatocytes | ↓ Serum aminotransferases | [50-54] |
Systemic inflammation | ↓ Serum IL-6 and tumor necrosis factor alpha | [51-53] |
Bacterial translocation | ↓ Serum lipopolysaccharide | [51-54] |
Gut dysbiosis | ↑ Firmicutes, Clostridiales and Lactobacillales; ↓ Proteobacteria and Campylobacterales | [51,53] |
Damage to the intestinal epithelium | ↓ Serum diamine oxidase | [53] |
Increased intestinal permeability | ↓ Serum D-lactate, ↑ the amount of occludin and other protein of tight junction in the gut epithelium, ↓ intestinal permeability for dyes | [50,52-54] |
Dyslipidemia | ↓ Serum cholesterol and triglycerides | [50,52-54] |
Disorder | Biomarker changes | Ref. |
Liver steatosis | ↓ Liver mass, the size and number of lipid droplets, the content of triglycerides, free fatty acids, and cholesterol in the liver tissues | [60-66] |
Obesity | ↓ Body mass, subcutaneous fat | [61-63,65,66] |
Intensified lipogenesis | ↓ Expression of the genes of sterol regulatory element-binding protein 1c (SREBP-1c), 3-hydroxy-3-methylglutaryl-CoA reductase, acetyl-CoA carboxylase 1, acetyl-CoA acetyltransferase 2, and fatty acid synthase, ↑ activated 5' adenosine monophosphate-activated protein kinase (SREBP-1c inhibitor) | [60,62,65,66] |
Reduced lipolysis | ↑ Expression of the gene of peroxisome proliferator-activated receptor alpha (fatty acid catabolism enhancer) and acyl-CoA oxidase | [60,62] |
Bile acid metabolism disorders | ↑ Expression of the gene of bile salt export pump, farnesoid X recetor, cholesterol 7a-hydroxylase, sodium taurocholate cotransporting polypeptide, ↓ the content of bile acids in the liver tissues | [62] |
Oxidative stress | ↓ Total reactive oxygen species, lipid peroxidates, and malondialdehyde and ↑ glutathione, superoxide dismutase, and catalase in the liver tissue | [60,61,65,66] |
Liver inflammation | ↓ Expression of the genes of tumor necrosis factor alpha, interleukin 1-beta and 6 and the content of NF-κB in the liver | [60] |
Death of hepatocytes | ↓ Serum aminotransferases | [60,61,65] |
Insulin resistance | ↓ HOMA-IR, insulin, resistin | [63,64] |
Systemic inflammation | ↓ Serum tumor necrosis factor alpha, interleukin 1-beta and 6 | [60,64] |
Bacterial translocation | ↓ Serum lipopolysaccharide | [64] |
Increased gut permeability | ↑ Amount of proteins of tight junction in the gut | [64] |
Disorders of the metabolism of carbohydrates and lipids | ↓ Serum total cholesterol, low density lipoprotein cholesterol, glucose, triglycerides, and free fatty acids, ↑ expression of the gene of low-density lipoprotein receptor | [60-62,65,66] |
- Citation: Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Probiotics in hepatology: An update. World J Hepatol 2021; 13(9): 1154-1166
- URL: https://www.wjgnet.com/1948-5182/full/v13/i9/1154.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i9.1154